Posts Tagged ‘NYSE’

FUL fully wonderful, AA busy, LAS in reverse

Wednesday, January 12th, 2011

H.B. Fuller Co. (NYSE: FUL) stock was up 15.1 percent to $23.00 after the adhesives manufacturer projected 2011 profit exceeding the consensus estimate. Volume for the stock was 1,386,133 shares, compared to its daily average of 225,469

Alcoa Inc. (NYSE: AA) traded in 42,082,114 shares Wednesday, besting its daily average of 26,060,100. Prices for AA were flat at $16.24. Wednesday, an analyst at RBC Dominion Securities downgraded the stock to “underperform” from “sector perform.”

Lentuo International Inc. (NYSE: LAS) fell 6 percent Wednesday to $5.76 Volume for the stock was 161,996 shares, surpassing its daily average of 97,159. LAS is the largest non-state-owned automobile retailer in Beijing.

PDFS triumphs, F active, GASS runs out of fuel

Wednesday, January 12th, 2011

PDF Solutions Inc. (Nasdaq: PDFS) shares gained 18.3% to $5.68 Wednesday. Volume of 268,590 proved nearly triple its full-day average. San Jose-based PDFS is the leading provider of yield improvement technologies and services for the integrated circuit (IC) manufacturing process life cycle.

Ford Motor Company (NYSE: F) traded in 37,503,600 shares Wednesday, approaching its daily average of 82,793,000. Prices for F nudged ahead 1.3 percent to $18.51.

Stealth Gas Inc, (Nasdaq: GASS) fell 6.6 percent Wednesday to $7.59 Volume for the stock was 145,497 shares, better than 2 1/2 its daily average. Greek-based GASS, a ship-owning company, primarily serves the liquified petroleum gas sector of the international shipping industry.

AFFX affirmative, S does business, SPMD slumps

Wednesday, January 12th, 2011

Affymetrix Inc. (Nasdaq: AFFX) shares gained 16.4% to $5.46 Wednesday. Volume of 1,666,321 proved nearly double its full-day average. The rise comes after the company said it expects to report a profit in the fourth quarter and announced that it signed a distribution deal with Thermo Fisher Scientific.

Sprint Nextel Corporation (NYSE: S) traded in 39,482,210 shares Wednesday, approaching its daily average of 45,195,800. Prices for S nudged ahead 0.3 percent to $4.41.

SuperMedia Inc. (Nasdaq: SPMD) fell 7.2 percent Wednesday to $8.82 Volume for the stock was 443,787 shares, surpassing its daily average of 396,158. SPMD is an advertising agency for local small- to medium-sized businesses across the United States.

ITT is it, GE active, CPF falters

Wednesday, January 12th, 2011

ITT Corp. (NYSE: ITT) shares gained 13.9% to $60.10 Wednesday after the defense contractor said it would split into three separate publicly traded companies. Volume of 14,510,255 overwhelmed a full-day average of 1,262,170.

General Electric Company (NYSE: GE) traded in 31,018,867 shares Wednesday, just better than half its all-day average of 57,041,400. Prices for GE were flat at $18.64. Wednesday, GE Intelligent Platforms announced the PCIE-5565PIORC low profile PCI Express reflective memory node card

Central Pacific Financial Corp. (NYSE: CPF) fell 8.2 percent Wednesday to $2.25. Volume for the stock was 924,167 shares or nearly 4 1/2 times its daily average, only a day after double-digit stock gains.

SDIX soars, BAC busy, KV troubled

Wednesday, January 12th, 2011

Strategic Diagnostics Inc. (Nasdaq: SDIX) shares shot higher 42.5 percent Wednesday to $2.65, on volume of 2,094,668 shares, towering over its full-day average of about 31,000. SDIX announced Wednesday its RapidChek SELECT Salmonella Enteritidis (SE) test system has been reviewed by FDA and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.

Bank of America Corp. (NYSE: BAC) traded in 113,699,846 shares noon Wednesday, nearly half its all-day average. Prices for BAC moved forward 1.8 percent to $14.95, as part of a general upward trend for bank stocks.

K-V Pharmaceutical Company (NYSE: KV.A) fell 21.9 percent Wednesday to $1.78. Volume for the stock was 1,722,746 shares or nearly five times its daily verage, after the company said it was “evaluating its liquidity outlook” in light of a delay by U.S. regulators over approval of a treatment to prevent preterm birth.